DCF — PROVIDENCE VALDEZ MEDICAL CENTER
Enterprise Value: $13.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$13.5M
Enterprise Value
$3.5M
PV of Cash Flows
$10.1M
PV of Terminal Value
$16.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $20.6M | $1.8M | 9.0% | $0.6M | $0.6M |
| Year 2 | $21.3M | $2.1M | 10.0% | $0.8M | $0.7M |
| Year 3 | $21.9M | $2.4M | 11.0% | $1.0M | $0.7M |
| Year 4 | $22.6M | $2.6M | 11.0% | $1.1M | $0.8M |
| Year 5 | $23.2M | $2.7M | 12.0% | $1.2M | $0.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $13.5M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$20.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08358790254575199
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5